Corbus Pharmaceuticals Holdings earnings were -$40.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CRBP earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$9.5M, down 30.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CRBP reported annual earnings of -$40.2M, with -9.9% growth. The next CRBP earnings date is May 5, 2025.
Corbus Pharmaceuticals Holdings Earnings Reports & History FAQ
What were Corbus Pharmaceuticals Holdings's earnings last quarter?
On CRBP's earnings call on Invalid Date, Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) reported Q4 2024 earnings per share (EPS) of -$0.76, up 57.54% year over year. Total CRBP earnings for the quarter were -$9.53 million. In the same quarter last year, Corbus Pharmaceuticals Holdings's earnings per share (EPS) was -$1.79.
When does Corbus Pharmaceuticals Holdings report earnings?
The next CRBP earnings date is Invalid Date. Add CRBP to your watchlist to be reminded of Corbus Pharmaceuticals Holdings's next earnings date.
What was CRBP's earnings growth in the past year?
As of Corbus Pharmaceuticals Holdings's earnings date in Invalid Date, Corbus Pharmaceuticals Holdings's earnings has grown year over year. CRBP earnings in the past year totalled -$40.21 million.
Is Corbus Pharmaceuticals Holdings profitable or losing money?
As of the last Corbus Pharmaceuticals Holdings earnings report, Corbus Pharmaceuticals Holdings is currently losing money. Corbus Pharmaceuticals Holdings's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$40.21 million, a 9.85% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.